Bnp Paribas Asset Management Holding S.A. Amicus Therapeutics, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 05, 2021	SELL	$9.2 - $23.86 $8.03 Million - $20.8 Million	-872,803 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$13.47 - $24.89 $9.27 Million - $17.1 Million	-687,830 Reduced 44.07%	872,803 $20.2 Million
Q3 2020 Nov 09, 2020	BUY	$12.89 - $15.89 $2.6 Million - $3.21 Million	202,088 Added 14.88%	1,560,633 $22 Million
Q2 2020 Aug 04, 2020	SELL	$8.86 - $15.69 $4.51 Million - $7.98 Million	-508,588 Reduced 27.24%	1,358,545 $20.5 Million
Q1 2020 May 12, 2020	SELL	$6.63 - $11.16 $1.65 Million - $2.78 Million	-249,332 Reduced 11.78%	1,867,133 $17.3 Million
Q4 2019 Feb 11, 2020	BUY	$7.48 - $10.75 $3.41 Million - $4.9 Million	455,637 Added 27.43%	2,116,465 $20.6 Million
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $165,155 - $272,857	20,593 Added 1.26%	1,660,828 $13.3 Million
Q2 2019 Aug 02, 2019	BUY	$10.96 - $14.4 $1.45 Million - $1.91 Million	132,642 Added 8.8%	1,640,235 $20.5 Million
Q1 2019 Apr 26, 2019	SELL	$10.04 - $13.92 $57,529 - $79,761	-5,730 Reduced 0.38%	1,507,593 $20.5 Million
Q4 2018 Feb 13, 2019	SELL	$8.38 - $13.44 $286,244 - $459,083	-34,158 Reduced 2.21%	1,513,323 $14 Million
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $5.38 Million - $7.67 Million	463,448 Added 42.75%	1,547,481 $18.7 Million
Q2 2018 Aug 01, 2018	BUY	$13.13 - $17.09 $2.26 Million - $2.94 Million	171,937 Added 18.85%	1,084,033 $16.9 Million
Q1 2018 May 07, 2018	BUY	$13.76 - $17.12 $12.6 Million - $15.6 Million	912,096 New	912,096 $13.7 Million

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.